GURUFOCUS.COM » STOCK LIST » Technology » Software » Enfusion Inc (NYSE:ENFN) » Definitions » Price-to-Free-Cash-Flow

Enfusion (Enfusion) Price-to-Free-Cash-Flow : 76.67 (As of May. 16, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Enfusion Price-to-Free-Cash-Flow?

As of today (2024-05-16), Enfusion's share price is $9.43. Enfusion's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 was $0.12. Hence, Enfusion's Price-to-Free-Cash-Flow Ratio for today is 76.67.

The historical rank and industry rank for Enfusion's Price-to-Free-Cash-Flow or its related term are showing as below:

ENFN' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 52.55   Med: 73.71   Max: 292.68
Current: 75.28

During the past 5 years, Enfusion's highest Price-to-Free-Cash-Flow Ratio was 292.68. The lowest was 52.55. And the median was 73.71.

ENFN's Price-to-Free-Cash-Flow is ranked worse than
84.33% of 1468 companies
in the Software industry
Industry Median: 22.8 vs ENFN: 75.28

Enfusion's Free Cash Flow per Share for the three months ended in Mar. 2024 was $-0.01. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was $0.12.

During the past 12 months, the average Free Cash Flow per Share Growth Rate of Enfusion was 6.00% per year.

During the past 5 years, Enfusion's highest 3-Year average Free Cash Flow per Share Growth Rate was -16.00% per year. The lowest was -16.00% per year. And the median was -16.00% per year.


Enfusion Price-to-Free-Cash-Flow Historical Data

The historical data trend for Enfusion's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Enfusion Price-to-Free-Cash-Flow Chart

Enfusion Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Free-Cash-Flow
- - - 132.47 78.86

Enfusion Quarterly Data
Dec19 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 90.52 82.50 57.13 78.86 75.20

Competitive Comparison of Enfusion's Price-to-Free-Cash-Flow

For the Software - Application subindustry, Enfusion's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Enfusion's Price-to-Free-Cash-Flow Distribution in the Software Industry

For the Software industry and Technology sector, Enfusion's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Enfusion's Price-to-Free-Cash-Flow falls into.



Enfusion Price-to-Free-Cash-Flow Calculation

Enfusion's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=9.43/0.123
=76.67

Enfusion's Share Price of today is $9.43.
Enfusion's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.12.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

Enfusion  (NYSE:ENFN) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


Enfusion Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Enfusion's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Enfusion (Enfusion) Business Description

Industry
Traded in Other Exchanges
N/A
Address
125 South Clark Street, Suite 750, Chicago, IL, USA, 60603
Enfusion Inc is a software-as-a-service (SaaS) provider focused on transforming the investment management industry. Its solutions are designed to eliminate technology and information barriers, empowering investment managers to make and execute better-informed investment decisions in real-time. It simplifies investment and operational workflows by unifying mission-critical systems and coalescing data into a single dataset resulting in a single source of truth.
Executives
Deirdre Somers director C/O ENFUSION, INC., 125 SOUTH CLARK STREET, SUITE 750, CHICAGO IL 60603
Bradley Herring officer: Chief Financial Officer C/O SHIFT4 PAYMENTS, INC., 2202 N. IRVING STREET, ALLENTOWN PA 16109
Oleg Movchan director, 10 percent owner C/O ENFUSION INC., 125 SOUTH CLARK ST. STE 750, CHICAGO IL 60603
Bronwen Bastone officer: Chief People Officer C/O ENFUSION, INC., 125 SOUTH CLARK STREET SUITE 750, CHICAGO IL 60603
Stephen Malherbe 10 percent owner C/O ENFUSION, INC., 125 SOUTH CLARK STREET, SUITE 750, CHICAGO IL 60603
Dan Groman officer: Chief Technology Officer C/O ENFUSION INC., 125 SOUTH CLARK STREET STE. 750, CHICAGO IL 60603
Tarek Hammoud 10 percent owner C/O ENFUSION INC., 125 SOUTH CLARK ST. STE. 750, CHICAGO IL 60603
Ftv Investment Holdings, L.p. 10 percent owner 601 CALIFORNIA STREET, FLOOR 19, SAN FRANCISCO CA 94108
Michael Spellacy director 399 PARK AVENUE, NEW YORK NY 10022
Quiet Light Securities, Llc 10 percent owner 70 WEST MADISON, SUITE 1675, CHICAGO IL 60602
Steven M. Bachert officer: Chief Revenue Officer C/O ENFUSION INC., 125 SOUTH CLARK ST., STE 750, CHIGAGO IL 60603
Lra Ventures, Llc 10 percent owner C/O ENFUSION, INC., 125 SOUTH CLARK STREET, SUITE 750, CHICAGO IL 60603
Hillhouse Investment Management, Ltd. 10 percent owner OFFICE #122, WINDWARD 3 BUILDING, REGATTA OFFICE PARK, WEST BAY ROAD, GRAND CAYMAN E9 KY1-9006
Roy Luo director 394 PACIFIC AVENUE, 2ND FLOOR, SAN FRANCISCO CA 94111
Iconiq Strategic Partners V-b, L.p. 10 percent owner 394 PACIFIC AVENUE, SECOND FLOOR, SAN FRANCISCO CA 94111

Enfusion (Enfusion) Headlines